EXPLORE OUR NEWEST WHITEPAPER
Modernizing Glaucoma Trials: Emerging Trends Shaping Clinical Development
This whitepaper outlines strategic recommendations for Sponsors, emphasizing the importance of partnering with a full-service, global ophthalmology CRO to optimize clinical development and enhance the success rates of glaucoma therapies.
This whitepaper outlines strategic recommendations for Sponsors, emphasizing the importance of partnering with a full-service, global ophthalmology CRO to optimize clinical development and enhance the success rates of glaucoma therapies.
Leading Ophthalmology CRO
Making the Complex Seamless® in Global Ophthalmology Clinical Trials
Drive the successful execution of Phase I-IV ophthalmology clinical trials through a partner with strong communication, coupled with early planning and experience collaborating with global regulatory authorities. Sponsors from emerging biotechs to global pharmaceutical companies have trusted Medpace for over 30 years to lead their ophthalmology development across a wide range of indications, including but not limited to:
- Age-Related Macular Degeneration
- Cornea
- Glaucoma
- Cataracts
- Diabetic Macular Edema
- Inherited Retinal Disease
